| 000 | 01742 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518090023.0 | ||
| 264 | 0 | _c20200721 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a2791-6421 | ||
| 024 | 7 |
_a10.24953/turkjped.2019.05.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaçyıldız, Nurdan | |
| 245 | 0 | 0 |
_aA targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. _h[electronic resource] |
| 260 |
_bThe Turkish journal of pediatrics _c2019 |
||
| 300 |
_a671-676 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBrentuximab Vedotin _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 |
_aHodgkin Disease _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSalvage Therapy _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTanyıldız, Hikmet Gülşah | |
| 700 | 1 | _aÜnal, Emel | |
| 700 | 1 | _aDinçaslan, Handan | |
| 700 | 1 | _aAsarcıklı, Fikret | |
| 700 | 1 | _aAksoy, Başak Adaklı | |
| 700 | 1 | _aVatansever, Göksel | |
| 700 | 1 | _aYavuz, Gülsan | |
| 773 | 0 |
_tThe Turkish journal of pediatrics _gvol. 61 _gno. 5 _gp. 671-676 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.24953/turkjped.2019.05.005 _zAvailable from publisher's website |
| 999 |
_c30679530 _d30679530 |
||